Rafael Holdings, Inc. (RFL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Rafael Holdings, Inc. (RFL) has a cash flow conversion efficiency ratio of -0.090x as of January 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-7.51 Million) by net assets ($83.26 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Rafael Holdings, Inc. (RFL) net asset quality to measure how much of total assets are equity-financed.
Rafael Holdings, Inc. - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Rafael Holdings, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Rafael Holdings, Inc. earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Rafael Holdings, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Rafael Holdings, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DeviceENG.CO.Ltd
KQ:187870
|
0.004x |
|
Viva Leisure Ltd
AU:VVA
|
0.366x |
|
M & A EQUITY HOLDINGS BERHAD
KLSE:7082
|
-0.069x |
|
FCW Holdings Bhd
KLSE:2755
|
-0.061x |
|
ATW Technology Inc
TWO:8097
|
-0.004x |
|
Sound Financial Bancorp Inc
NASDAQ:SFBC
|
0.018x |
|
Intelligent Digital Integrated Security Co. Ltd
KQ:143160
|
0.041x |
|
Silitech Technology Corp
TW:3311
|
-0.019x |
Annual Cash Flow Conversion Efficiency for Rafael Holdings, Inc. (2016–2025)
The table below shows the annual cash flow conversion efficiency of Rafael Holdings, Inc. from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see RFL market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-07-31 | $98.37 Million | $-18.92 Million | -0.192x | -112.69% |
| 2024-07-31 | $86.26 Million | $-7.80 Million | -0.090x | +19.71% |
| 2023-07-31 | $96.63 Million | $-10.89 Million | -0.113x | +58.01% |
| 2022-07-31 | $97.21 Million | $-26.08 Million | -0.268x | -135.09% |
| 2021-07-31 | $136.70 Million | $-15.60 Million | -0.114x | -219.25% |
| 2020-07-31 | $130.53 Million | $-4.67 Million | -0.036x | -42.40% |
| 2019-07-31 | $124.76 Million | $-3.13 Million | -0.025x | -59.84% |
| 2018-07-31 | $115.56 Million | $-1.81 Million | -0.016x | +39.93% |
| 2017-07-31 | $62.08 Million | $-1.62 Million | -0.026x | -1872.49% |
| 2016-07-31 | $48.81 Million | $72.00K | 0.001x | -- |
About Rafael Holdings, Inc.
Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells… Read more